ARDX - What's Going On With Ardelyx Stock? | Benzinga
Ardelyx, Inc. (NASDAQ: ARDX) shares are trading higher Monday after the company provided a strategic business update. Here's a look at what's going on.
The Details:
Ardelyx released a business update Monday stating that the company expects its FDA-approved IBS treatment, Ibsrela, to achieve greater than ten percent market share at peak and generate more than $1.0 billion in annual U.S. net product sales revenue before the patent term expiration.
The company also stated that it expects full-year 2024 ...